Allergies in Medical Technology

Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis

... them have long noticed a correlation between allergies and IC. Recently, a urologist and allergist in ... "Until now, the evidence linking IC and allergies has been circumstantial," said Barbara Gordon, ... IC. "Epidemiologic studies show the prevalence of allergies in IC patients to be higher than in people in ...

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

... Canada, will enrol 48 patients with confirmed cat allergies and cat-allergen induced asthma. The ... target patient group to those with more serious allergies that can result in asthma attacks," said Steve ... $12 billion per year. The prevalence of cat allergies is also high, with 1-in-6 Americans and nearly ...

New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly

... are not the Only Way We Suffer - allergies Impact Mood and Self-Perception KENILWORTH, ... 20 /PRNewswire-FirstCall/ -- Indoor and outdoor allergies affect about 50 million people in the United ... Allergies," a national telephone survey, allergies are often disregarded as a nuisance: in today's ...

Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet

... is the only treatment option that treats the immunological causes of allergies and modifies the natural course of the disease, preventing it from ... program, which aims to address the immunological cause of respiratory allergies with EBM-documented, registered allergen tablets. This program consists in ...

Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children

... of atopic dermatitis and prevent or delay the development of other related allergies -- such as food allergies and asthma that affect many patients with atopic dermatitis. "Atopic ...

Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment

... treatments is approximately $12 billion per year. The prevalence of cat allergies is high, with 1-in-6 Americans and nearly 10% of Europeans suffering from the condition. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization ...

Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology

... study in Germany, where patients with a confirmed history of cat allergies received a single dose of ToleroMune therapy or placebo. The 88 study ... Goldman Sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization ...

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

... effectively and safely by Prednisporin(TM)." Allergic conjunctivitis is a frequent disorder. It occurs in up to 90% of patients suffering from allergies and in more than 20% of the global population. In the USA alone, 80 million people experience ocular surface allergy and inflammation. More than 50% ...

Study Confirms: Your Hidden Food Allergies Are Making You Fat

... sensitivities helped the weight loss process, people looked at me like I had two heads," says Roger Deutsch, co-author of the book, Your Hidden Food allergies are Making You Fat. "Now we know that chronic inflammation, caused primarily by exposure to incompatible foods, is at the root of metabolic problems ...

Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis

... therapy for EoE," states Malcolm R. Hill, Pharm.D., chief scientific officer of Meritage Pharma, Inc. "Patients with EoE struggle with apparent allergies to many foods and other allergens, and it is often difficult to eliminate possible symptom triggers. Meritage Pharma is eager to evaluate OVB as a ...

IBT Laboratories Expands its Menu of Tests for Immune Deficiency

... The company has recently expanded its research capacity and will be offering other new tests in the future to help doctors treat patients with allergies and immune deficiencies. About IBT Laboratories A clinical diagnostic and research laboratory specializing in immunology and ...

Burcon announces GRAS status for Puratein(R) & Supertein(TM)

... GRAS through an independent evaluation by a panel of qualified experts in the fields of food safety, toxicology, nutritional sciences, food allergies and pediatric nutrition. Burcon's Puratein(R) and Supertein(TM) are the first canola protein isolates to have attained GRAS status in the United ...

Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology

... institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, ToleroMune. The company is also developing its ToleroTrans organ ...

National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities

... Tinkelman, MD, Vice President of Health Initiatives at National Jewish. "Because one out of every two American households has someone suffering from allergies and/or asthma, we believe the Family Air Care(TM) assessment is a tremendous initial product for our partnership." "Roche is committed to ...

June 2008 Mayo Clinic Women's HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing

... of postherpetic neuralgia cases. The vaccine, given in a single dose, is not appropriate for adults with weakened immune systems and those with allergies to gelatin, the antibiotic neomycin or any component of the shingles vaccine. The vaccine is an option for people who've had shingles and at least ...

AlphaVax Continues to Expand the Use of Its Vaccine Platform

... RESEARCH TRIANGLE PARK, N.C., June 6 /PRNewswire/ -- AlphaVax, Inc. recently received notification from the National Institute of allergies and Infectious Diseases (NIAID), one of the granting institutes of the National Institutes of Health (NIH), that it has been awarded a second grant ...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

... suggest heart problems, such as chest pain or fainting. DAYTRANA should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of DAYTRANA; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOI); ...

Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology

... leveraging its proprietary immune amplification platform technology, Genetic Immunity aims to create new markets for infectious diseases, cancer and allergies through the discovery, development and commercialization of topically administered nanomedicines. These indications represent a significant unmet ...

FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

... rhinitis (SAR), commonly referred to as "hay fever" or "outdoor allergies," is the most common form of allergic rhinitis. By definition, SAR includes allergies to seasonal pollens like grass, trees, and weeds, as well as mold. Perennial Allergic Rhinitis (PAR) is sometimes referred to as "year round" or ...

Study Says Allergy Shots Help Children, Reduce Health Care Costs

... duration were sufficient." "The research pioneered by BioMedEcon illustrates both the importance of allergy immunotherapy for children with allergies and the economic incentives for ensuring they are appropriately treated," said Robert Esch, Ph.D., Executive Vice President of Research and ...

New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis

... passages to allergens, such as dust mites, animal dander, mold spores, and pollens. One of the most prevalent and chronic diseases in the U.S., nasal allergies affect up to 40 million people annually, including 10 to 30 percent of adults and up to 40 percent of children. Within minutes of exposure to an ...

New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo

... health care provider. Important Safety Information CONCERTA(R) should not be taken by patients with: significant anxiety, tension or agitation; allergies to methylphenidate or other ingredients in CONCERTA(R); glaucoma; Tourette's syndrome, tics or family history of Tourette's syndrome. Abuse of ...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

... suggest heart problems, such as chest pain or fainting. Daytrana should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of Daytrana; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOI); ...

Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine

... potential should avoid becoming pregnant during treatment with Taxotere(R). Before receiving Taxotere(R), tell your doctor if -- You have any allergies -- You are taking any other medicines - including nonprescription (over- the-counter) drugs, vitamins, and dietary or herbal supplements When ...

Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic

... with non-dialysis dependent CKD, hypertension, coronary artery disease, cerebrovascular disease and a history of multiple drug allergies to ciprofloxacin, levofloxacin, and percocet. The patient experienced an anaphylactoid reaction with severe hypotension a few ...

New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate

... symptoms. Important Safety Information OROS(R) methylphenidate should not be taken by patients with significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients in OROS(R) methylphenidate; glaucoma; Tourette's syndrome, tics or family history of Tourette's syndrome; or ...

New Data Focuses on Abuse of Stimulant Medication

... symptoms. Important Safety Information OROS(r) methylphenidate should not be taken by patients with significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients in OROS(r) methylphenidate; glaucoma; Tourette's syndrome, tics or family history of Tourette's syndrome; or ...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

... heart problems, such as chest pain or fainting. Daytrana should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of Daytrana; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOI); ...

First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy

... Allergic Response" published in the July 1 issue of the Journal of Immunology, setting the stage for the development of new potential therapies for allergies using nanomaterials. Kent Murphy, CEO, Luna Innovations, noted about the immunology discovery and publication, "Luna's collaborations with ...

Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

... minimized. PreHistin is patented for the treatment of atopic allergic diseases such as seasonal and perennial allergies, dermatitis, migraine, food allergies and asthma. About Cobalis Corp. Cobalis Corp. is a specialty pharmaceutical development company specializing in medications to prevent and treat ...